Voisin Consulting Life Sciences glossary icon
Glossary

Pre-Sub Meeting

Loading..
Click a letter to view all its definitions

FDA Pre-Sub meetings are available for manufacturers to obtain regulatory feedback on various medical device applications in the US in the frame of clinical studies (i.e. Investigational Device Exemptions IDE), or premarket regulatory submissions (i.e. 510(k), De Novo, PMA etc.). The FDA Pre-Sub program can prove especially valuable for innovative medical devices for which predicate devices are difficult to identify.

Other glossary definitions

E

End of Trial (EoT) Declaration

Clinical trial sponsors are required to notify regulatory authorities and ethics committees when their clinical…

View definition
C

Clinical Evaluation Report (CER)

Required under the new MEDDEV 2.7.1 Rev. 3 guidelines. Document containing information and results generated…

View definition